Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
8.02
-0.51 (-5.98%)
At close: Aug 20, 2026, 4:00 PM EDT
8.16
+0.14 (1.75%)
After-hours: Aug 20, 2026, 7:30 PM EDT

Achieve Life Sciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-58.28-54.88-39.07-27.25-40.8-33.09
Net Income
-114.04-54.65-39.83-29.82-42.35-33.15
Earnings Per Share
-1.81-1.25-1.24-1.50-4.00-4.08
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
187.336.434.3615.5524.7743.02
Total Debt
14.9514.969.9616.7316.214.99
Net Cash (Debt)
172.3621.4524.4-1.198.5728.03
Net Cash Growth
279.33%-12.10%---69.41%-21.62%
Net Cash Per Share
2.730.490.76-0.060.813.45

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-47.02-49.47-29.77-24.48-37.57-29.44
Capital Expenditures
-0.02-0--0.02--
Free Cash Flow
-47.04-49.47-29.77-24.5-37.57-29.44
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.